The estimated Net Worth of Roy S Roberts is at least $5.45 Millón dollars as of 20 October 2009. Roy Roberts owns over 6,413 units of Abbvie Inc stock worth over $5,454,941 and over the last 21 years Roy sold ABBV stock worth over $0.
Roy has made over 2 trades of the Abbvie Inc stock since 2008, according to the Form 4 filled with the SEC. Most recently Roy exercised 6,413 units of ABBV stock worth $239,974 on 20 October 2009.
The largest trade Roy's ever made was exercising 9,427 units of Abbvie Inc stock on 8 February 2008 worth over $329,945. On average, Roy trades about 990 units every 39 days since 2004. As of 20 October 2009 Roy still owns at least 28,033 units of Abbvie Inc stock.
You can see the complete history of Roy Roberts stock trades at the bottom of the page.
Roy's mailing address filed with the SEC is North Waukegan Road, North Chicago, Lake County, Illinois, 60044, United States.
Over the last 12 years, insiders at Abbvie Inc have traded over $324,915,370 worth of Abbvie Inc stock and bought 214,015 units worth $14,446,494 . The most active insiders traders include Richard A Gonzalez, Frederick H Waddell y Glenn F Tilton. On average, Abbvie Inc executives and independent directors trade stock every 22 days with the average trade being worth of $7,529,855. The most recent stock trade was executed by Richard A Gonzalez on 5 August 2024, trading 66,500 units of ABBV stock currently worth $12,403,580.
AbbVie Inc. is a pharmaceutical company headquartered in North Chicago, Illinois. It is ranked 6th on the list of largest biomedical companies by revenue. Their primary product is Humira (adalimumab) ($21 billion in 2022 revenues, 37% of total), administered via injection. It is approved to treat autoimmune diseases including rheumatoid arthritis, Crohns disease, plaque psoriasis, and ulcerative colitis.
Abbvie Inc executives and other stock owners filed with the SEC include: